4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 101 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRANKLIN RESOURCES INC | 14,416 | $260,498 | 0.00% |
| Newbridge Financial Services Group, Inc. | 30 | $542 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 12,586 | $227,429 | 0.00% |
| AMALGAMATED BANK | 3,252 | $59 | 0.00% |
| JANE STREET GROUP, LLC | 41,783 | $755,019 | 0.00% |
| ROYAL BANK OF CANADA | 3,223 | $59,000 | 0.00% |
| US BANCORP \DE\ | 264 | $4,770 | 0.00% |
| FMR LLC | 2,832 | $51,174 | 0.00% |
| Bank of New York Mellon Corp | 116,277 | $2,101,125 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,575 | $28,460 | 0.00% |
| Citadel Advisors | 10,100 | $182,507 | 0.00% |
| Citadel Advisors | 12,000 | $216,840 | 0.00% |
| Citadel Advisors | 18,885 | $341,252 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50,400 | $910,728 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17,100 | $308,997 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,041 | $18,811 | 0.00% |
| Legal & General Group Plc | 24,176 | $436,860 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22,548 | $407,442 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 2,190 | $38 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 12,713 | $229,724 | 0.00% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q2 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.